A new agent developed by biotransformation of polyphyllin VII inhibits chemoresistance in breast cancer-Reference-Cited by-同舟云学术

A new agent developed by biotransformation of polyphyllin VII inhibits chemoresistance in breast cancer

Published:2015-12-19 Issue:22 Volume:7 Page:31814-31824
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

He Dong-Xu¹,Li Guo-Hong²,Gu Xiao-Ting¹,Zhang Liang¹,Mao Ai-Qin¹,Wei Juan¹,Liu De-Quan³,Shi Gui-Yang¹,Ma Xin¹

Affiliation:

1. School of Pharmaceutical Sciences National Engineering, and Laboratory for Cereal Fermentation Technology, Jiangnan University, Wuxi 214122, China

2. Laboratory for Conservation and Utilization of Bio-Resources, and Key Laboratory for Microbial Resources of The Ministry of Education, Yunnan University, Kunming 650091, China

3. Department of Breast Surgery, The Third Affiliated Hospital, Kunming Medical University, Kunming 650031, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyphyllin VII Promotes Apoptosis in Breast Cancer by Inhibiting MAPK/ERK Signaling Pathway through Downregulation of SOS1;The American Journal of Chinese Medicine;2024-01

2. Polyphyllin VII as a Potential Drug for Targeting Stemness in Hepatocellular Cancer via STAT3 Signaling;Current Cancer Drug Targets;2023-04

3. A simple and sensitive LC–MS/MS method for the determination of polyphyllin VII in rat plasma and its application to pharmacokinetic study;Biomedical Chromatography;2023-03-09

4. Polyphyllin VII induces CTC anoikis to inhibit lung cancer metastasis through EGFR pathway regulation;International Journal of Biological Sciences;2023

5. Polyphyllin VII is a Potential Drug Targeting CD44 Positive Colon Cancer Cells;Current Cancer Drug Targets;2022-05